Expansion Opportunities The company recently expanded facilities across the United Kingdom, Northern Europe, and Europe, indicating ongoing capacity growth and potential demand for orthopaedic devices, wound care products, and related IT upgrades. Sales teams can target new and upgraded centers with integrated solutions and service contracts.

Cartilage Regeneration Strategic interest in cartilage regeneration is evidenced by the planned CartiHeal acquisition and the Perceive3D technology integration. This suggests growing demand for advanced biologics, implants, and imaging/3D planning tools in cartilage repair markets.

Ambulatory Strategy Launch of ASC Solutions signals a push toward ambulatory surgery centers with a focus on cost, quality, and outcome performance. This creates opportunities to offer compact, ship-ready devices, streamlined workflows, and ASC-specific service packages.

Profitability Momentum Strong H1 revenue growth with trading margins improving to 18.3% and robust earnings indicate financial health and willingness to invest in new technology, acquisitions, and capex favorable to customers seeking reliable, innovative devices and integration capabilities.

Digital & Data Enablement The tech stack includes analytics and execution platforms (Celonis, IQVIA, Movemedical, E2open) suggesting readiness for digital solutions, data-driven outcomes tracking, and supply chain collaboration. There is selling potential for connected devices, remote monitoring, and integrated procurement/fulfillment offerings.